Literature DB >> 15726235

Evidence-based guidelines for the treatment of postmenopausal osteoporosis: a consensus document of the Belgian Bone Club.

Steven Boonen1, Jean-Jacques Body, Yves Boutsen, Jean-Pierre Devogelaer, Stefan Goemaere, Jean-Marc Kaufman, Serge Rozenberg, Jean-Yves Reginster.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15726235     DOI： 10.1007/s00198-004-1812-1

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  108 in total

1.  Risk factors for falls as a cause of hip fracture in women. The Northeast Hip Fracture Study Group.

Authors:  J A Grisso; J L Kelsey; B L Strom; G Y Chiu; G Maislin; L A O'Brien; S Hoffman; F Kaplan
Journal:  N Engl J Med       Date:  1991-05-09       Impact factor: 91.245

2.  A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group.

Authors:  C H Chesnut; S Silverman; K Andriano; H Genant; A Gimona; S Harris; D Kiel; M LeBoff; M Maricic; P Miller; C Moniz; M Peacock; P Richardson; N Watts; D Baylink
Journal:  Am J Med       Date:  2000-09       Impact factor: 4.965

3.  Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial.

Authors:  P D Delmas; H K Genant; G G Crans; J L Stock; M Wong; E Siris; J D Adachi
Journal:  Bone       Date:  2003-10       Impact factor: 4.398

4.  Soy isoflavones have a favorable effect on bone loss in Chinese postmenopausal women with lower bone mass: a double-blind, randomized, controlled trial.

Authors:  Yu-Ming Chen; Suzanne C Ho; Silvia S H Lam; Susan S S Ho; Jean L F Woo
Journal:  J Clin Endocrinol Metab       Date:  2003-10       Impact factor: 5.958

5.  Effects of phytoestrogens on bone turnover in postmenopausal women with a history of breast cancer.

Authors:  Eini Nikander; Merja Metsä-Heikkilä; Olavi Ylikorkala; Aila Tiitinen
Journal:  J Clin Endocrinol Metab       Date:  2004-03       Impact factor: 5.958

6.  Bone mass and structure are enhanced following a 2-year randomized controlled trial of exercise in prepubertal boys.

Authors:  Kerry J MacKelvie; Moira A Petit; Karim M Khan; Thomas J Beck; Heather A McKay
Journal:  Bone       Date:  2004-04       Impact factor: 4.398

7.  Effect of raloxifene on the risk of new vertebral fracture in postmenopausal women with osteopenia or osteoporosis: a reanalysis of the Multiple Outcomes of Raloxifene Evaluation trial.

Authors:  John A Kanis; Olof Johnell; Dennis M Black; Robert W Downs; Somnath Sarkar; Thomas Fuerst; Roberta J Secrest; Imre Pavo
Journal:  Bone       Date:  2003-09       Impact factor: 4.398

8.  Stronger back muscles reduce the incidence of vertebral fractures: a prospective 10 year follow-up of postmenopausal women.

Authors:  M Sinaki; E Itoi; H W Wahner; P Wollan; R Gelzcer; B P Mullan; D A Collins; S F Hodgson
Journal:  Bone       Date:  2002-06       Impact factor: 4.398

9.  Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture.

Authors:  J A Kanis; O Johnell; B Gullberg; E Allander; G Dilşen; C Gennari; A A Lopes Vaz; G P Lyritis; G Mazzuoli; L Miravet
Journal:  BMJ       Date:  1992-11-07

Review 10.  Osteoporosis prevention with sex hormone replacement therapy.

Authors:  S Rozenberg; J Vandromme; M Kroll; A Pastijn; M Degueldre
Journal:  Int J Fertil Menopausal Stud       Date:  1994 Sep-Oct
View more
  21 in total

Review 1.  Development and use of FRAX in osteoporosis.

Authors:  J A Kanis; E V McCloskey; H Johansson; A Oden; O Ström; F Borgström
Journal:  Osteoporos Int       Date:  2010-05-13       Impact factor: 4.507

Review 2.  Salmon calcitonin: a review of current and future therapeutic indications.

Authors:  C H Chesnut; M Azria; S Silverman; M Engelhardt; M Olson; L Mindeholm
Journal:  Osteoporos Int       Date:  2007-12-11       Impact factor: 4.507

3.  [Prevalence and management of osteoporosis in trauma surgery. Implementation of national guidelines during inpatient fracture treatment].

Authors:  F Haasters; W C Prall; M Himmler; H Polzer; M Schieker; W Mutschler
Journal:  Unfallchirurg       Date:  2015-02       Impact factor: 1.000

4.  Evidence-based guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: a consensus document of the Belgian Bone Club.

Authors:  Jean-Pierre Devogelaer; Stefan Goemaere; Steven Boonen; Jean-Jacques Body; Jean-Marc Kaufman; Jean-Yves Reginster; Serge Rozenberg; Yves Boutsen
Journal:  Osteoporos Int       Date:  2005-10-11       Impact factor: 4.507

Review 5.  Strontium ranelate: a review of its use in the treatment of postmenopausal osteoporosis.

Authors:  Emma D Deeks; Sohita Dhillon
Journal:  Drugs       Date:  2010-04-16       Impact factor: 9.546

6.  The problem of low levels of vitamin D and osteoporosis: use of combination therapy with alendronic acid and colecalciferol (vitamin D3).

Authors:  Sol Epstein
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

7.  Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club.

Authors:  J-J Body; P Bergmann; S Boonen; Y Boutsen; J-P Devogelaer; S Goemaere; J-M Kaufman; S Rozenberg; J-Y Reginster
Journal:  Osteoporos Int       Date:  2010-05-18       Impact factor: 4.507

8.  Cost-utility of long-term strontium ranelate treatment for postmenopausal osteoporotic women.

Authors:  M Hiligsmann; O Bruyère; J-Y Reginster
Journal:  Osteoporos Int       Date:  2009-04-07       Impact factor: 4.507

Review 9.  Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club.

Authors:  P Bergmann; J-J Body; S Boonen; Y Boutsen; J-P Devogelaer; S Goemaere; J-M Kaufman; J-Y Reginster; V Gangji
Journal:  Int J Clin Pract       Date:  2009-01       Impact factor: 2.503

Review 10.  European guidance for the diagnosis and management of osteoporosis in postmenopausal women.

Authors:  J A Kanis; N Burlet; C Cooper; P D Delmas; J-Y Reginster; F Borgstrom; R Rizzoli
Journal:  Osteoporos Int       Date:  2008-02-12       Impact factor: 4.507
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.